So, I was curious if anyone would be willing to explain their general approach
Thinking about what I actually do, I don’t think this is an easy question to answer.
When seeing a patient for the first time, one of the first things that I will always do is to confirm or clarify the actual diagnosis even if one is specified on the referral letter. Not all “depression” is actually clinical depression, and could be part of an anxiety, bipolar, substance use or personality disorder which will alter the treatment accordingly.
But let’s say a patient actually does have a major depressive disorder, and they tell me that they’ve tried a couple of antidepressants that didn’t work. While I can accept this at face value, I still need to explore a few other things to inform my management.
For each antidepressant tried, I need to know whether a patient has had an adequate trial or not. I will ask something along the lines of, “What was the highest dose and long did you take it for?” The approach to someone who has taken 60mg of escitalopram for 6 months vs someone on 25mg of sertraline for 2 weeks is going to be markedly different.
I also need to know about any side effects with past medications. Sometimes these actually are due to the medications, but if patients are not taking their treatments consistently they may actually be reporting withdrawal symptoms which may allow past treatments to be reconsidered.
Sometimes patients will tell me they started taking the medication and then it stopped working. While not an exhaustive list, broadly speaking the main reasons that patients might give to explain this happening are:
1) They stopped taking it because they started feeling better
2) The medication spontaneously stopped working
3) There have been new situational stressors
For 1), I’d be more inclined to restart the medication, with psychoeducation about the long term risks regarding ceasing treatment and relapsing. Patients are often concerned about the prospects of having to take something forever and require reassurance that this may not actually be the case.
For 2), I might consider a dose increase or augmentation. A change in drug could also be indicated – which may be cross taper, taper to zero/washout, or straight swap – this is determined by the medications currently being used and considered as well as the patient’s individual risk profile.
For 3), many different approaches could apply.
-If the stressor needs to be actively addressed, attempt to do so. Eg. “I don’t have a pill that will fix the problems you’re having with your partner. Have you thought about seeing a relationship counsellor?”
-If the stressor is expected to pass, it could be reasonable to leave medications as they are and continue to monitor the patient’s mental state.
-The dose could also be increased, either immediately or as a later option if distress remains even after the stressor has passed.
-Some PRN medications could be prescribed in the short term or until the stress passes.
-If something has happened very recently, then some level of distress would be expected, and it may be too early to make any changes.
There may be other biological factors that need to be explored. For the most part our GPs are good at ruling out or managing existing organic conditions, but I always take my own medical history too. As an example, some months ago I saw a patient who had been stable for many years, but started to report a pattern of mood instability. It turned out that just after I last saw them they had their HRT medications altered and the mood swings were triggered when taking the progesterone pills. CC’d their gynaecologist in my letter, they changed the HRT and things went back to the way they used to be.
To make private practice viable, a lot of what will happens treatment wise requires some buy-in from the patient. Part of my job is to discuss the various treatment options with them. I’ll emphasise what course of action I think should occur and the reasons behind this, but ultimately it comes down to their choice. Obviously if they demand something I’m unwilling to provide or isn’t indicated I’ll send them elsewhere, but this is rarely an issue. More typically, I find that patients will be more in favour of either medications or therapy, and there’s usually no issue with going down one pathway before the other with the other option as a backup that can be considered later on.